Abstract
<b>Watch the video or read the poster to learn:</b><!--StartFragment--> <ul data-stringify-type="unordered-list" class="p-rich_text_list p-rich_text_list__bullet" data-indent="0"><li data-stringify-indent="0">Why the large batch sizes needed for mesenchymal stromal cell (MSC) therapy present unique culture challenges</li><li data-stringify-indent="0">How Corning® High Yield Performance (HYPER) technology allows users to perform adherent cell culture in a compact footprint</li><li data-stringify-indent="0">Viability, cellular yields, and marker expression data for umbilical-derived MSCs cultured using HYPER technology</li></ul> <!--EndFragment--><div class="authors authors-lg"><div class="author"><div class="author-img"><img src="https://cdn.insights.bio/uploads/ff143ff5a43741a492177c547f5f63d3.png" data-image="1"></div><div class="author-det"> <b>About the speaker</b> Catherine Siler is an accomplished Field Application Scientist for Corning Life Sciences, with a PhD in Biology from Johns Hopkins University. Dr Siler enables scientists and researchers in the life science industry to overcome challenges with cell culture and scale-up for clinical manufacturing of advanced therapies, and utilizes her research and teaching experience to drive the adoption of an industry-leading global product portfolio of innovative single-use consumables for research, process development and bioprocessing applications. </div></div></div>
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
